BEST-CLI 中西班牙裔患者接受开放旁路术的结局
该研究为 BEST-CLI 试验的二次分析,合并两个开放手术队列共 634 例患者(西班牙裔 106 例,非西班牙裔白人 528 例),比较术后 1 年截肢、再干预、主要肢体不良事件和生存率。校正混杂因素后,西班牙裔 ethnicity 与上述结局均无显著关联。
要点
- 西班牙裔患者较白人更年轻、糖尿病和终末期肾病比例更高、从不吸烟者更多、术前踝肱指数更高。
- 校正年龄、性别、糖尿病、终末期肾病、吸烟史、膝下病变、WIfI 分期和既往血运重建后,西班牙裔与主要截肢、主要再干预、主要肢体不良事件及生存均无显著关联。
- 作者认为未来 PAD 临床试验应纳入就医可及性和及时性指标,以评估基于流行病学和回顾性研究认为高风险人群的差异结局风险。
核心结论
- 在 BEST-CLI 试验中接受开放血运重建的西班牙裔患者,未观察到肢体相关结局的差异。
- 作者建议未来 PAD 临床试验应捕获就医可及性和及时性的指标,以评估基于流行病学和回顾性研究认为高风险的 PAD 人群的差异结局风险。
研究设计与样本
- BEST-CLI 试验的二次分析,合并开放手术队列(队列1:适合单段大隐静脉,n=484;队列2:缺乏适合单段大隐静脉,n=150),共 634 例接受开放手术旁路的患者。
- 按 ethnicity 分组比较术后 1 年结局:踝上截肢、主要再干预、主要肢体不良事件(主要截肢和主要再干预的复合终点)和生存。
- 构建 Cox 回归模型确定西班牙裔 ethnicity 与开放手术旁路后选定终点的关联。
主要发现
- 634 例开放手术旁路患者中,非西班牙裔白人 528 例(83.3%),西班牙裔 106 例(16.7%)。
- 与白人患者相比,西班牙裔患者更年轻(64.6 ± 8.6 岁 vs 68.5 ± 9.6 岁;P < .001),糖尿病比例更高(91.5% vs 66.3%;P < .001),终末期肾病比例更高(15.1% vs 6.8%;P = .005),从不吸烟者更多(44.3% vs 16.2%;P < .001)。
- 西班牙裔患者术前踝肱指数更高(0.7 ± 0.4 vs 0.5 ± 0.3;P < .001)。
- 校正年龄、性别、糖尿病、终末期肾病、吸烟史、膝下病变、WIfI 分期和既往下肢血运重建后,西班牙裔 ethnicity 与主要截肢(aHR 0.67;95%CI 0.30-1.48)、主要再干预(aHR 0.81;95%CI 0.35-1.87)、主要肢体不良事件(aHR 0.64;95%CI 0.34-1.21)及生存(aHR 0.69;95%CI 0.42-1.13)在术后 1 年均无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Hispanic patients have a higher prevalence of peripheral artery disease (PAD) risk factors, undergo revascularization at lower rates, and have higher rates of major amputation. This study compares outcomes after open surgical revascularization within the Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) Trial between Hispanic and non-Hispanic White patients. METHODS: In a secondary analysis of BEST-CLI, open surgical cohorts were combined (cohort 1, suitable single segment greater saphenous vein [n = 484]; cohort 2, lack of suitable single segment greater saphenous vein [n = 150]) and examined, by ethnicity, for the following 1-year outcomes: (1) above-ankle amputation, (2) major reintervention, (3) major adverse limb event (a composite of major amputation and major reintervention), and (4) survival. Cox regression models were constructed to determine the association between Hispanic ethnicity and selected endpoints after surgical bypass for patients enrolled in BEST-CLI. RESULTS: Of the 634 patients who underwent open surgical bypass, 528 (83.3%) were non-Hispanic White (White) and 106 (16.7%) were Hispanic. Compared with White patients, Hispanic patients were younger (64.6 ± 8.6 years vs 68.5 ± 9.6 years; P < .001), had a higher proportion of diabetes (91.5% vs 66.3%; P < .001), end-stage renal disease (15.1% vs 6.8%; P = .005), and were more often never smokers (44.3% vs 16.2%; P < .001). Preoperative ankle-brachial index was higher among Hispanic patients (0.7 ± 0.4 vs 0.5 ± 0.3; P < .001). After controlling for age, sex, diabetes, end-stage renal disease, smoking history, infrapopliteal disease, Wound Ischemia foot Infection stage, and previous lower extremity revascularization, Hispanic ethnicity was not significantly associated with major amputation (adjusted hazard ratio [aHR], 0.67; 95% confidence interval [CI], 0.30-1.48), major reintervention (aHR, 0.81; 95% CI, 0.35-1.87), major adverse limb event (aHR, 0.64; 95% CI, 0.34-1.21), or survival (aHR, 0.69; 95% CI, 0.42-1.13) 1 year after surgical bypass. CONCLUSIONS: Disparities in limb-related outcomes were not observed for Hispanic patients undergoing open revascularization in BEST-CLI. Future PAD clinical trials should capture metrics of access to care, and timeliness of care for assessing risk of disparate outcomes among PAD populations thought to be at higher risk based on epidemiological and retrospective studies.
引用
- Ulloa JG, Alabi O, McGinigle K, et al. Outcomes for Hispanic patients undergoing open bypass in BEST-CLI. J Vasc Surg. 2025. PMID: 39914761. doi:10.1016/j.jvs.2025.01.212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。